Loading clinical trials...
Loading clinical trials...
A Phase 3 International, Multicenter, Double-Blind, Placebo-Controlled, Randomized Trial Evaluating the Efficacy and Safety of Multiple Instillations of Intravesical Apaziquone vs. Placebo in Patients With Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer (NMIBC)
Conditions
Interventions
Apaziquone
Placebo
Locations
47
United States
Valley Urologic Associates
Glendale, Arizona, United States
Precision Trials, LLC
Phoenix, Arizona, United States
South Orange County Medical Research Center
Laguna Woods, California, United States
The Urology Center of Colorado
Denver, Colorado, United States
Connecticut Clinical Research Center
Middlebury, Connecticut, United States
Urology Enterprises
Marietta, Georgia, United States
Start Date
July 1, 2011
Primary Completion Date
March 1, 2014
Completion Date
March 1, 2014
Last Updated
December 13, 2016
NCT00026884
NCT04235764
NCT03375307
NCT07061964
NCT07050771
NCT04585750
Lead Sponsor
Spectrum Pharmaceuticals, Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions